Foundation to Eradicate Duchenne

Q: What is Foundation to Eradicate Duchenne's official website?

Foundation to Eradicate Duchenne's official website is www.duchennemd.org

Q: What is Foundation to Eradicate Duchenne's Revenue?

Foundation to Eradicate Duchenne's revenue is <$5 Million

Q: What is Foundation to Eradicate Duchenne's SIC code?

Foundation to Eradicate Duchenne's SIC: 83,839

Q: What is Foundation to Eradicate Duchenne's NAICS code?

Foundation to Eradicate Duchenne's NAICS: 81,813

Q: How many employees does Foundation to Eradicate Duchenne have?

Foundation to Eradicate Duchenne has 11-50 employees

Q: What industry does Foundation to Eradicate Duchenne belong to?

Foundation to Eradicate Duchenne is in the industry of: Non-Profit & Charitable Organizations , Organizations

Q: What is Foundation to Eradicate Duchenne competition?

Foundation to Eradicate Duchenne top competitors include: Epirium , Dracaena Consulting , Mirum , Cao Pharmaceuticals

Q: What technology does Foundation to Eradicate Duchenne use?

Some of the popular technologies that Foundation to Eradicate Duchenne uses are: WordPress.org, PHP, MailChimp, Google Font API

Q: What does Foundation to Eradicate Duchenne do?

ReveraGen BioPharma Inc. is focused on developing first-in-class dissociative steroidal drugs for Duchenne muscular dystrophy (DMD) and other chronic inflammatory disorders. Their lead compound, vamorolone, has shown promising efficacy in clinical trials and is supported by partnerships with various foundations and government agencies. The company... aims to provide innovative treatment options for patients suffering from DMD, a rare genetic disease primarily affecting young boys. ReveraGen collaborates with a wide range of stakeholders to advance drug development and improve patient outcomes. Read More

Q: What are Foundation to Eradicate Duchenne social media links?

Foundation to Eradicate Duchenne Linkedin page Foundation to Eradicate Duchenne Twitter page Foundation to Eradicate Duchenne Facebook page

Non-Profit & Charitable Organizations · Virginia, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

PO Box 2371, Alexandria, Virginia, 22301...

Website

www.duchennemd.org

Revenue

<$5 Million

Industry

Non-Profit & Charitable Organizations

Organizations

ZI Rank: 1

Signal Type

Mar

Apr

May

Jun

Jul

Aug

ZI Rank

About Foundation to Eradicate Duchenne

ReveraGen BioPharma Inc. is focused on developing first-in-class dissociative steroidal drugs for Duchenne muscular dystrophy (DMD) and other chronic inflammatory disorders. Their lead compound, vamorolone, has shown promising efficacy in clinical trials and is supported by partnerships with various foundations and government agencies. The company aims to provide innovative treatment options for patients suffering from DMD, a rare genetic disease primarily affecting young boys. ReveraGen collaborates with a wide range of stakeholders to advance drug development and improve patient outcomes.Explore more

Is this data correct?

View contact profiles from Foundation to Eradicate Duchenne

Popular SearchesFoundation to Eradicate Duchenne IncDuchenne Muscular DystrophyDuchenneDuchenne Musular DystrophyFoundation To Eradicate Duchenne, Duchenne Muscula...SIC Code 83,839NAICS Code 81,813Show more

Foundation to Eradicate Duchenne Org Chart

Phone

Joel Wood

President

Phone

Get the full picture

Is Foundation to Eradicate Duchenne your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Congratulate Masked Content for being promoted to Masked Content at Foundation to Eradicate Duchenne

Check if Foundation to Eradicate Duchenne has recently received funding, and reach out quickly before it becomes old news!

Foundation to Eradicate Duchenne, which may be a good buyer, showed buying intent in Masked Content Topic

Product Launch: Get notified when Foundation to Eradicate Duchenne launches new products

Check out if Foundation to Eradicate Duchenne is spiking on competitors!

Funding: Get notified immidiatlly once Foundation to Eradicate Duchenne has new funding data

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Click to see if Foundation to Eradicate Duchenne had a recent Job posting/layoffs

Earning: See what the market has to say on Foundation to Eradicate Duchenne recently announced quarterly report

Website visits: Recent activity has been detected on your website

Recommended Actions

Introduce yourself to Masked Content, who has shown a strong intent to purchase lately

Find 2 more new buyers

Compare Similar Companies to Foundation to Eradicate Duchenne

Compare insights from companies similar to Foundation to Eradicate Duchenne, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Foundation to Eradicate D...

<$5M

11-50

Private

2002

Joel WoodPresident

Clintrex

<$5M

11-50

Private

2010

C. OlanowCEO

Receptor Life Sciences

<$5M

11-50

Private

$39.7M

2015

Traci CarmanFounder & Chief Financial Officer, Amp & Director, Amp

Dracaena Consulting

<$5M

1-10

Private

2006

N/A

Mirum

<$5M

11-50

Private

N/A

Cao Pharmaceuticals

<$5M

11-50

Private

2014

Douglas CoilClinical Director & Vice President, Operations

Epirium

<$5M

11-50

Private

2008

Christopher OlisAssociate Director, Accounting

View Email Formats for Foundation to Eradicate Duchenne

Among all Organizations companies

Low Activity

High Activity

Activity Insights

Foundation to Eradicate Duchenne is experiencing very low activity levels compared to other companies in the Organizations sector.

What does this means?

Foundation to Eradicate Duchenne is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Foundation to Eradicate Duchenne.

Foundation to Eradicate Duchenne Tech Stack

A closer look at the technologies used by Foundation to Eradicate Duchenne

PHP

See more technologies

Foundation to Eradicate Duchenne News & Media

Global Duchenne Muscular Dystrophy Drugs Market Report 2021: Clinical Trials Depict Emflaza Preserves Motor Function Better than Corticosteroids - Forecast to 2027 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Duchenne Muscular Dystrophy Drugs - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Duchenne Muscular Dystrophy Drugs Market to Reach $7 Billion by 2027 Amid the COVID-19 crisis, the global market for Duchenne Muscular Dystrophy Drugs estimated at US$706.5 Million in the year 2020, is projected to reach a revised size of US$7 Billion by 2027, growing at a CAGR of 38.8% over the analysis period 2020-2027.
www.businesswire.com
United States Duchenne Muscular Dystrophy Market and Competitive Landscape Report 2021 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "US Duchenne Muscular Dystrophy Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. US Duchenne Muscular Dystrophy Market and Competitive Landscape Highlights - 2021, provides comprehensive insights into Duchenne Muscular Dystrophy pipeline products, Duchenne Muscular Dystrophy epidemiology, Duchenne Muscular Dystrophy market valuations and forecast, Duchenne Muscular Dystrophy drugs sales and competitive landscape in
www.businesswire.com
United States Duchenne Muscular Dystrophy Market Report 2020 - Pipeline, Epidemiology, Key Products, Market Valuations & Forecast, Drugs Sales and Market Shares
Dublin, Sept. 04, 2020 (GLOBE NEWSWIRE) -- The "US Duchenne Muscular Dystrophy Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering. The report provides comprehensive insights into Duchenne Muscular Dystrophy pipeline products, Duchenne Muscular Dystrophy epidemiology, Duchenne Muscular Dystrophy market valuations and forecast, Duchenne Muscular Dystrophy drugs sales and competitive landscape in the US. The research is classified into seven sections
www.globenewswire.com
Duchenne Muscular Dystrophy in the U.S. - Market and Competitive Landscape Analysis 2016-2025 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "US Duchenne Muscular Dystrophy Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering. The report provides comprehensive insights into Duchenne Muscular Dystrophy pipeline products, Duchenne Muscular Dystrophy epidemiology, Duchenne Muscular Dystrophy market valuations and forecast, Duchenne Muscular Dystrophy drugs sales and competitive landscape in the US. The research is classified into seven sections - Duchenne Muscu
www.businesswire.com
Global Duchenne Muscular Dystrophy Market (2020 to 2024) - Develop In-depth Knowledge of Competition and Markets - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Duchenne Muscular Dystrophy Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights into the Duchenne Muscular Dystrophy pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Duchenne Muscular Dystrophy market size and drug sales. It also provides insights into Duchenne Muscular
www.businesswire.com

Top Non-Profit & Charitable Organizations Companies

Frequently Asked Questions Regarding Foundation to Eradicate Duchenne

What is Foundation to Eradicate Duchenne's official website?

Foundation to Eradicate Duchenne's official website is www.duchennemd.org

What is Foundation to Eradicate Duchenne's Revenue?

Foundation to Eradicate Duchenne's revenue is <$5 Million

What is Foundation to Eradicate Duchenne's SIC code?

Foundation to Eradicate Duchenne's SIC: 83,839

What is Foundation to Eradicate Duchenne's NAICS code?

Foundation to Eradicate Duchenne's NAICS: 81,813

How many employees does Foundation to Eradicate Duchenne have?

Foundation to Eradicate Duchenne has 11-50 employees

What industry does Foundation to Eradicate Duchenne belong to?

Foundation to Eradicate Duchenne is in the industry of: Non-Profit & Charitable Organizations, Organizations

What is Foundation to Eradicate Duchenne competition?

Foundation to Eradicate Duchenne top competitors include: Epirium, Dracaena Consulting, Mirum, Cao Pharmaceuticals

What technology does Foundation to Eradicate Duchenne use?

Some of the popular technologies that Foundation to Eradicate Duchenne uses are: WordPress.org, PHP, MailChimp, Google Font API

What does Foundation to Eradicate Duchenne do?

What are Foundation to Eradicate Duchenne social media links?

Foundation to Eradicate Duchenne Linkedin page Foundation to Eradicate Duchenne Twitter page Foundation to Eradicate Duchenne Facebook page

Is Foundation to Eradicate Duchenne a public company?

Foundation to Eradicate Duchenne is private company therefore does not currently have an official ticker symbol

See more information about Foundation to Eradicate Duchenne

Sell Smarter. Win Faster.

Level up your game to ZoomInfo Copilot, intuitive AI that turns your data and high-quality ZoomInfo data into an unfair advantage for your go-to-market teams.